中超控股(002471.SZ):定增項目實施後,江蘇精鑄將形成年產1000噸高温合金精密鑄件的生產能力
格隆匯1月5日丨中超控股(002471.SZ)在投資者互動平台表示,公司定增項目實施後,江蘇精鑄將形成年產1,000噸高温合金精密鑄件的生產能力,發展為我國航空航天高温合金特種產品產業示範基地和國際大型複雜薄壁高温合金精密鑄件的主要供應商,成為航發賽道中的核心企業。項目系公司提升高温合金精密鑄件產業化能力、研發實力及市場開拓能力從而進一步提升核心競爭力的重要舉措,有利於提升公司市場影響力、提高上市公司盈利能力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.